歯科用生体材料のオーストラリア・ニュージーランド市場2020-2027:種類別(金属生体材料、セラミック生体材料、高分子生体材料、金属セラミック生体材料、天然生体材料、複合材料生体材料)、用途別、エンドユーザー別、地域別

【英語タイトル】Australia & New Zealand Dental Biomaterials Market Size, Share & Trends Analysis Report By Type (Metallic Biomaterials, Ceramic Biomaterials), By Application, By End-use, By Region, And Segment Forecasts, 2020 - 2027

Grand View Researchが出版した調査資料(GV21JA049)・商品コード:GV21JA049
・発行会社(調査会社):Grand View Research
・発行日:2020年11月12日
・ページ数:85
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:オーストラリア、ニュージーランド
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Multi UserUSD6,950 ⇒換算¥722,800見積依頼/購入/質問フォーム
Enterprise UserUSD8,950 ⇒換算¥930,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
グランドビューリサーチ社は、歯科用生体材料のオーストラリア、ニュージーランド市場規模が2027年までに48.3百万ドルに達すると予測しています。2020年から2027年までに年平均8.6%成長する見通しです。本市場調査資料では、歯科用生体材料のオーストラリア・ニュージーランド市場を広く調査・分析し、手法・範囲、エグゼクティブサマリー、市場変化・動向・範囲、種類別分析、用途別分析、エンドユーザー別分析、地域別分析、競争状況など、以下の構成でまとめております。
【レポートの概要】

Australia & New Zealand Dental Biomaterials Market Growth & Trends
The Australia & New Zealand dental biomaterials market size is expected to reach USD 48.3 million by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.6% from 2020 to 2027. Dental biomaterials include the biocompatible synthetic materials and natural tissues that are used to restore damaged, decayed, or fractured teeth. There are different types of natural dental tissues, such as dentin, enamel, bone, cementum, and other intraoral tissues. These dental tissues are used in the treatment of various dental diseases. With the increasing prevalence of various oral diseases, the demand for dental biomaterials is also increasing. Hence, the market is estimated to witness lucrative growth over the forecast period.

The increasing prevalence of oral diseases, the rising dental tourism in emerging countries, and the growing geriatric population are some of the major factors driving the market. According to the survey carried out by the Australian Institute of Health and Welfare in 2019, oral health contributes to 4.5% of all the burden diseases, such as gum disease, tooth decay, and tooth loss. Oral diseases are the most expensive diseases to be treated in developed as well as developing countries. The dental biomaterials accounted for 5.0% of the overall health expenditure in developed countries, like Australia. Dental biomaterials are promising products and have a high success rate in oral prevention and treatment. This factor is anticipated to boost the growth of the market over the forecast period.

Increasing the edentulous population is also one of the reasons responsible for market growth. The promptly increasing number of qualified dental professionals is anticipated to increase access to dental care. Australia held the largest share of over 65.0% in 2019 due to its technological improvement in dental biomaterials, rising aging population, and increasing investment in R&D. Moreover, the growing collaborations between hospitals and academic institutions, widespread R&D activities at the industrial and academic levels, and increase in the application scope of dental biomaterials, such as orthodontics and implantology, have fueled the market growth over the forecast period. Furthermore, the presence of major players has contributed to market growth.

Australia & New Zealand Dental Biomaterials Market Report Highlights

• By type, the metallic biomaterials segment dominated the market in 2019 with a share of 34.8% owing to the increasing prevalence of dental diseases and the rising demand for dental biomaterials in developing countries

• The ceramic biomaterials type segment is anticipated to register the fastest CAGR of 9.1% over the forecast period

• The implantology application segment accounted for the largest share of 43.1% in 2019 and is anticipated to maintain its lead owing to growing dental problems

• Australia held the largest share of over 65.0% in 2019. This can be attributed to the rapid increase in the development of dental biomaterials to meet the growing demand for efficient healthcare in the country

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key service scopes to conclude on the market size
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. ANZ Dental Biomaterials Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Service
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Growing prevalence of dental caries
3.4.1.2. Increasing awareness about oral health
3.4.1.3. Technological advancements pertaining to dental procedures
3.4.2. Market Restraint Analysis
3.4.2.1. Decrease government funding on dental care
3.4.3. Industry Challenges
3.4.3.1. Managing the relationships
3.5. ANZ Dental Biomaterials: Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Type Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
Chapter 4. ANZ Dental Biomaterials: Segment Analysis, by Type, 2016 – 2027 (USD Million)
4.1. Definitions & Scope
4.2. Type market share analysis, 2019 & 2027
4.3. Segment Dashboard
4.4. ANZ Dental Biomaterials Market, by Type, 2016 to 2027
4.5. Market Size & Forecasts and Trend Analysis, 2016 to 2027 for the following
4.5.1. Metallic Biomaterials
4.5.2. Ceramic Biomaterials
4.5.3. Polymeric Biomaterials
4.5.4. Metal-ceramic Biomaterials
4.5.5. Natural Biomaterials
4.5.6. Composites Biomaterials
Chapter 5. ANZ Dental Biomaterials: Segment Analysis, by Application, 2016 – 2027 (USD Million)
5.1. Definitions & Scope
5.2. Application market share analysis, 2019 & 2027
5.3. Segment Dashboard
5.4. ANZ Dental Biomaterials Market, by Application, 2016 to 2027
5.5. Market Size & Forecasts and Trend Analysis, 2016 to 2027 for the following
5.5.1. Orthodontics
5.5.2. Implantology
5.5.3. Prosthodontics
5.5.4. Others
Chapter 6. ANZ Dental Biomaterials: Segment Analysis, by End-Use, 2016 – 2027 (USD Million)
6.1. Definitions & Scope
6.2. End-use market share analysis, 2019 & 2027
6.3. Segment Dashboard
6.4. ANZ Dental Biomaterials Market, by End-Use, 2016 to 2027
6.5. Market Size & Forecasts and Trend Analysis, 2016 to 2027 for the following
6.5.1. Dental Hospitals and Clinics
6.5.2. Dental Laboratories
6.5.3. Dental Academies and Research Institutes
Chapter 7. ANZ Dental Biomaterials: Regional Market Analysis, 2016 – 2027 (USD Million)
7.1. Definitions & Scope
7.2. Regional Market Share Analysis, 2019 & 2027
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot
7.5. Regional Market Share, 2018
7.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
7.7. Australia
7.7.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
7.7.2. Market estimates and forecast, by Type, 2016 – 2027 (USD Million)
7.7.3. Market estimates and forecast, By Application, 2016 – 2027 (USD Million)
7.7.4. Market estimates and forecast, By End Use, 2016 – 2027 (USD Million)
7.8. New Zealand
7.8.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
7.8.2. Market estimates and forecast, by Type, 2016 – 2027 (USD Million)
7.8.3. Market estimates and forecast, By Application, 2016 – 2027 (USD Million)
7.8.4. Market estimates and forecast, By End Use, 2016 – 2027 (USD Million)
Chapter 8. ANZ Dental Biomaterials – Competitive Analysis
8.1. Key companies profiled
8.1.1. Straumann Holding AG
8.1.1.1. Company Overview
8.1.1.2. Financial Performance
8.1.1.3. Product Benchmarking
8.1.1.4. Strategic Initiatives
8.1.2. Geistlich Pharma AG
8.1.2.1. Company Overview
8.1.2.2. Financial Performance
8.1.2.3. Product Benchmarking
8.1.2.4. Strategic Initiatives
8.1.3. Zimmer Biomet Holding, Inc.
8.1.3.1. Company Overview
8.1.3.2. Financial Performance
8.1.3.3. Product Benchmarking
8.1.3.4. Strategic Initiatives
8.1.4. Danaher Corporation
8.1.4.1. Company Overview
8.1.4.2. Financial Performance
8.1.4.3. Product Benchmarking
8.1.4.4. Strategic Initiatives
8.1.5. Dentsply Sirona, Inc.
8.1.5.1. Company Overview
8.1.5.2. Financial Performance
8.1.5.3. Product Benchmarking
8.1.5.4. Strategic Initiatives
8.1.6. 3M Company
8.1.6.1. Company Overview
8.1.6.2. Financial Performance
8.1.6.3. Product Benchmarking
8.1.6.4. Strategic Initiatives
8.1.7. Royal DSM
8.1.7.1. Company Overview
8.1.7.2. Financial Performance
8.1.7.3. Product Benchmarking
8.1.7.4. Strategic Initiatives
8.1.8. Carpenter Technology Corporation
8.1.8.1. Company Overview
8.1.8.2. Financial Performance
8.1.8.3. Product Benchmarking
8.1.8.4. Strategic Initiatives
8.1.9. Kuraray Co. Ltd.
8.1.9.1. Company Overview
8.1.9.2. Financial Performance
8.1.9.3. Product Benchmarking
8.1.9.4. Strategic Initiatives
8.1.10. Medtronic
8.1.10.1. Company Overview
8.1.10.2. Financial Performance
8.1.10.3. Product Benchmarking
8.1.10.4. Strategic Initiatives
8.1.11. Henry Schein
8.1.11.1. Company Overview
8.1.11.2. Financial Performance
8.1.11.3. Product Benchmarking
8.1.11.4. Strategic Initiatives
8.1.12. Ivoclar Vivadent AG
8.1.12.1. Company Overview
8.1.12.2. Financial Performance
8.1.12.3. Product Benchmarking
8.1.12.4. Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 ANZ Dental Biomaterials Market, By Region 2016 - 2027 (USD Million)
Table 4 ANZ Dental Biomaterials Market, By Type, 2016 - 2027 (USD Million)
Table 5 ANZ Dental Biomaterials Market, By Application, 2016 - 2027 (USD Million)
Table 6 ANZ Dental Biomaterials Market, By End Use, 2016 - 2027 (USD Million)
Table 7 Australia ANZ Dental Biomaterials, By Country, 2016 - 2027 (USD Million)
Table 8 Australia ANZ Dental Biomaterials, By Type, 2016 - 2027 (USD Million)
Table 9 Australia ANZ Dental Biomaterials, By Application, 2016 - 2027 (USD Million)
Table 10 Australia ANZ Dental Biomaterials, By End Use, 2016 - 2027 (USD Million)
Table 11 New Zealand ANZ Dental Biomaterials, By Country, 2016 - 2027 (USD Million)
Table 12 New Zealand ANZ Dental Biomaterials, By Type, 2016 - 2027 (USD Million)
Table 13 New Zealand ANZ Dental Biomaterials, By Application, 2016 - 2027 (USD Million)
Table 14 New Zealand ANZ Dental Biomaterials, By End Use, 2016 - 2027 (USD Million)


List of Figures

Fig. 1 ANZ dental biomaterials market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity Flow Analysis
Fig. 10 Volume Price Analysis
Fig. 11 ANZ dental biomaterials market snapshot (2019)
Fig. 12 Parent market outlook
Fig. 13 Ancillary market outlook
Fig. 14 Penetration & growth prospect mapping
Fig. 15 Market driver relevance analysis (Current & future impact)
Fig. 16 Market restraint relevance analysis (Current & future impact)
Fig. 17 Porter’s five forces analysis
Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 19 ANZ dental biomaterials market type outlook: Segment dashboard
Fig. 20 ANZ dental biomaterials market: Type movement analysis
Fig. 21 Metallic biomaterials market, 2016 - 2027 (USD Million)
Fig. 22 Ceramic biomaterials market, 2016 - 2027 (USD Million)
Fig. 23 Polymeric biomaterials market, 2016 - 2027 (USD Million)
Fig. 24 Metal-ceramic biomaterials market, 2016 - 2027 (USD Million)
Fig. 25 Natural biomaterials market, 2016 - 2027 (USD Million)
Fig. 26 Composites biomaterials market, 2016 - 2027 (USD Million)
Fig. 27 ANZ dental biomaterials market application outlook: Segment dashboard
Fig. 28 ANZ dental biomaterials Market: Application movement analysis
Fig. 29 Orthodontics market, 2016 - 2027 (USD Million)
Fig. 30 Implantology market, 2016 - 2027 (USD Million)
Fig. 31 Prosthodontics market, 2016 - 2027 (USD Million)
Fig. 32 Others market, 2016 - 2027 (USD Million)
Fig. 33 ANZ dental biomaterials market end-use outlook: Segment dashboard
Fig. 34 ANZ dental biomaterials market: End-use movement analysis
Fig. 35 Dental hospitals and clinics market, 2016 - 2027 (USD Million)
Fig. 36 Dental laboratories market, 2016 - 2027 (USD Million)
Fig. 37 Dental academies and research institutes market, 2016 - 2027 (USD Million)
Fig. 38 Regional market: Key takeaways
Fig. 39 Regional outlook, 2019 & 2027
Fig. 40 Australia market, 2016 - 2027 (USD Million)
Fig. 41 New Zealand market, 2016 - 2027 (USD Million)

★調査レポート[歯科用生体材料のオーストラリア・ニュージーランド市場2020-2027:種類別(金属生体材料、セラミック生体材料、高分子生体材料、金属セラミック生体材料、天然生体材料、複合材料生体材料)、用途別、エンドユーザー別、地域別] (コード:GV21JA049)販売に関する免責事項を必ずご確認ください。
★調査レポート[歯科用生体材料のオーストラリア・ニュージーランド市場2020-2027:種類別(金属生体材料、セラミック生体材料、高分子生体材料、金属セラミック生体材料、天然生体材料、複合材料生体材料)、用途別、エンドユーザー別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆